Gland Pharma Ltd
Pharmaceuticals - Indian - Formulations
BSE Code:	543245	NSE Symbol:	GLAND	P/E :	21.74
ISIN Demat:	INE068V01023	Div & Yield %:	1.35	EPS :	68.05
Book Value:	556.81	Market Cap (Rs. Cr.):	24,374.89	Face Value :	1

Gland Pharma's JNPC facility completes USFDA inspection	Back
(25 Feb 2025)
Gland Pharma announced that the United States Food and Drug Administration (US FDA) has conducted a Pre-approval inspection (PAI) for Sterile APIs at the Company's Facility at JNPC, Visakhapatnam between 19 February 2025 and 25 February 2025. The said inspection was concluded with THREE (3) Form 483 Observations. These observations are procedural in nature. The corrective and preventive actions for these observations will be submitted to the US FDA within the stipulated period. The observations issued are neither repeated observations nor related to data integrity.

Company Snapshot